|
| |
tamarkin acne Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - Tamarkin Pharmaceutical Innovation Limited - Profile
TU-2100 has been shown to be effective and safe in Phase II clinical studies in. acne,. BioNews Results for Tamarkin Pharmaceutical Innovation Limited ...
http://www.bioportfolio.com/biocorporate/10006-Tamarkin+Phar...
|
Technion - BME - Company entry - TAMARKIN PHARMACEUTICAL ...
TAMARKIN PHARMACEUTICAL INNOVATION LTD - Company entry: ... TPI's lead product, TU-2100, is aimed to treat acne, seborrhea and hair growth disorders. ...
http://www.bm.technion.ac.il/companies/company_view/226...
|
Intendis - Foamix and Intendis Sign License Agreement for the ...
... offering a broad spectrum of proven, outstanding products to treat acne, ... development of dermatological foams", said Foamix CEO, Dr. Dov Tamarkin. ...
http://www.intendis.com/scripts/pages/en/press_amp_media/new...
|
loftextEBSCOPub[filter] AND 0340-3696[ta] AND 1978:2008[dp ...
PMID: 18663457 [PubMed - in process] 7: Nahary L, Tamarkin A, Kayam N, Sela S, ... gene promoter polymorphism at position -308 and acne in Turkish patients.
...
http://www.ncbi.nlm.nih.gov/sites/entrez?term=loftextEBSCOPu...
|
PRESS RELEASE Foamix and Intendis Sign License Agreement for the ...
... in the development of dermatological foams", said Foamix CEO, Dr. Dov Tamarkin. ... dermatitis, as well as psoriasis, acne, rosacea and fungal skin
...
http://intendis.com/html/pdf/news/2007/070110_FoamixIntendis...
|
Percutaneous penetration and skin metabolism of et...[J Control ...
Sintov AC, Behar-Canetti C, Friedman Y, Tamarkin D. ... of a new potential anti- acne prodrug--TU-2100 [bis(o-carboxyphenyl ethyl ester)nonanedioate] in ...
http://www.ncbi.nlm.nih.gov/pubmed/11853923...
|
Intendis - Foamix und Intendis unterzeichnen Lizenzabkommen für ...
... offering a broad spectrum of proven, outstanding products to treat acne, ... fügte Foamix-CEO Dr. Dov Tamarkin hinzu. "Wir begrüßen diese Gelegenheit ...
http://www.intendis.com/scripts/pages/en/press_amp_media/new...
|
|
